ClearSight, a leading provider of advanced vision correction solutions, is now offering the PanOptix® Trifocal Intraocular ...

In the evolving field of neurodegenerative medicine, the challenge is not merely discovering new treatments but ensuri ...

Press Release Nicox Announces up to €3 million in Milestone Payments from Kowa in 2025 as NCX 470 Prepares to Enter Phase 3 ...

An inexpensive, long-approved HIV drug can improve vision in patients with a blinding complication of diabetes more ...

Vakharia insights from the ARCHER trial on geographic atrophy treatment for dry AMD, highlighting promising results and ...

An inexpensive, long-approved HIV drug can improve vision in patients with a blinding complication of diabetes more ...

Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by ...

LONG ISLAND - Michael, a 48-year-old from Suffolk County, is suing Ozempic's manufacturer for loss of vision. Michael, who opted out of sharing his surname, says that the loss of sight began after his ...

A widely available and low-cost HIV medication, lamivudine, may offer new hope for millions of people suffering from diabetic macular edema (DME), a leading cause of vision loss among diabetics.

Following his keynote address at Controversies in Modern Eye Care, Dr. Maloney said he will be leaving his surgical practice ...

NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentations of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of ...